Mathisen Berit, Lindstad Rune I, Hansen Janne, El-Gewely Sara Ann, Maelandsmo Gunhild M, Hovig Eivind, Fodstad Oystein, Loennechen Thrina, Winberg Jan-Olof
Department of Biochemistry, Institute of Medical Biology, University of Tromsø, Tromsø, Norway.
Clin Exp Metastasis. 2003;20(8):701-11. doi: 10.1023/b:clin.0000006819.21361.03.
To study the role of the metastasis associated protein S100A4, an osteosarcoma cell line (OHS) with a high level of this protein was transfected with a vector containing a ribozyme that degrades S100A4 mRNA and, as controls, OHS cells were transfected with the vector alone. We have followed up our previous investigation (Bjørnland et al. 1999) by a detailed investigation of these cell lines' synthesis of MMP and TIMP proteins at different cell densities. It is shown that the cell lines with a low S100A4 level produced a reduced amount of immunoreactive MMP-2 at cellular subconfluence, while at confluence there was no difference compared to the control cells. The cell lines with a reduced S100A4 level produced less of the activated form of MMP-2 (62-kDa) and less TIMP-1 than the corresponding control cells, independent of cell density. Isolated cell membranes from cell lines with a reduced S100A4 level contained less MT1-MMP, MMP-2 and TIMP-2 compared to the control cells. Activation of exogenously added proMMP-2 was less effective with the former membrane preparations. It appeared that the mechanism behind the S100A4 dependent activation of proMMP-2 varied with cell density, as SN50, a peptide inhibitor of NF-kappaB nuclear translocation reduced the activation of MMP-2 at low cell density, but had no effect at high cell density. Thus, one of the mechanisms by which S100A4 may exert its effect on metastasis of some tumors is by regulating the MMP-2 activity.
为研究转移相关蛋白S100A4的作用,用含有可降解S100A4 mRNA的核酶的载体转染了一株该蛋白水平较高的骨肉瘤细胞系(OHS),作为对照,仅用该载体转染OHS细胞。我们通过详细研究这些细胞系在不同细胞密度下MMP和TIMP蛋白的合成情况,对之前的研究(Bjørnland等人,1999年)进行了跟进。结果显示,S100A4水平低的细胞系在细胞亚汇合时产生的免疫反应性MMP-2量减少,而在汇合时与对照细胞相比无差异。S100A4水平降低的细胞系产生的活性形式的MMP-2(62-kDa)和TIMP-1比相应的对照细胞少,与细胞密度无关。与对照细胞相比,S100A4水平降低的细胞系的分离细胞膜中MT1-MMP、MMP-2和TIMP-2含量较少。用前一种细胞膜制剂对外源添加的proMMP-2的激活效果较差。似乎S100A4依赖的proMMP-2激活机制随细胞密度而变化,因为NF-κB核转位的肽抑制剂SN50在低细胞密度时降低了MMP-2的激活,但在高细胞密度时没有作用。因此,S100A4可能对某些肿瘤转移发挥作用的机制之一是通过调节MMP-2活性。